Cervical cancer: A global health crisis

William Small, Monica A. Bacon, Amishi Bajaj, Linus T. Chuang, Brandon J. Fisher, Matthew M. Harkenrider, Anuja Jhingran, Henry C. Kitchener, Linda R. Mileshkin, Akila N. Viswanathan, David K. Gaffney

Research output: Contribution to journalReview articlepeer-review


Cervical cancer is the fourth most common malignancy diagnosed in women worldwide. Nearly all cases of cervical cancer result from infection with the human papillomavirus, and the prevention of cervical cancer includes screening and vaccination. Primary treatment options for patients with cervical cancer may include surgery or a concurrent chemoradiotherapy regimen consisting of cisplatin-based chemotherapy with external beam radiotherapy and brachytherapy. Cervical cancer causes more than one quarter of a million deaths per year as a result of grossly deficient treatments in many developing countries. This warrants a concerted global effort to counter the shocking loss of life and suffering that largely goes unreported. This article provides a review of the biology, prevention, and treatment of cervical cancer, and discusses the global cervical cancer crisis and efforts to improve the prevention and treatment of the disease in underdeveloped countries. Cancer 2017;123:2404–12.

Original languageEnglish (US)
Pages (from-to)2404-2412
Number of pages9
Issue number13
StatePublished - Jul 1 2017


  • Cervix Cancer Research Network (CCRN)
  • Gynecological Cancer InterGroup (GCIG)
  • activism
  • brachytherapy
  • cervical cancer
  • chemotherapy
  • developing world
  • human papillomavirus (HPV)
  • vaccination

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Cervical cancer: A global health crisis'. Together they form a unique fingerprint.

Cite this